$QQQ $SPY August CPI in line to slightly hot
— Headline CPI MoM came in at 0.4%, matching forecast, up from 0.1% prior
— Headline CPI YoY held steady at 3.4%, in line with expectations
— Core CPI MoM ran hot at 0.3% vs 0.2% forecast
— Core CPI YoY eased slightly to 2.4% from 2.5%, matching forecast
— Mixed print, headline in line but core running a touch hotter month over month
Not financial advice.
$GOSS 1-for-80 reverse split now effective
— Became effective September 10 at 11:59pm ET, split-adjusted trading starts September 11 under existing ticker GOSS with new CUSIP
— Every 80 shares combined into 1, no fractional shares, fractions rounded up to nearest whole share
— Authorized shares cut from 4 billion to 50 million
— Convertible notes, warrants, and equity awards all proportionately adjusted
— Move aimed at regaining Nasdaq minimum bid price compliance, deadline is October 5
Not financial advice.
$GCTK announces $11.5M financing
— Convertible notes deal totaling about $11.5 million in aggregate principal
— Includes roughly $4.5 million new cash and $4.5 million of existing notes rolled over, with a 22% original issue discount
— Conversion price set at $3.12 per share
— Investors also getting warrants exercisable at $7.50 per share
— Dawson James Securities acted as sole placement agent
Not financial advice.
$TPST announces up to $7.5M private placement
— Selling 3,105,591 shares plus Series C and D warrants at $0.805 per share
— Initial gross proceeds expected around $2.5 million, with up to $5 million more if warrants are fully exercised
— Series C warrants exercisable for 6 years, Series D for 3 years, both pending stockholder approval
— H.C. Wainwright acting as exclusive placement agent
— Expected to close around September 14, proceeds earmarked for working capital and general corporate purposes
Not financial advice.
$CMND enrolls first AUD patients in CMND-100 trial
— First two patients with Alcohol Use Disorder enrolled at Hadassah Medical Center in Jerusalem
— First time CMND-100 has been administered to an AUD patient
— Drug is a non-hallucinogenic psychedelic-derived neuroplastogen candidate
— Trial evaluating safety, tolerability, pharmacokinetics, and preliminary efficacy
— Company previously tested CMND-100 across multiple doses in healthy participants before this stage
Not financial advice.
$MASK unveils Mikkeli data center blueprint built for Nvidia's Vera Rubin
— Physical infrastructure natively designed for Nvidia's next-gen Vera Rubin DSX architecture in Finland
— Initial deployment plans mix HGX clusters for AI training and MGX clusters for inference
— Facility built with direct-to-chip liquid cooling, reinforced flooring for near two-ton racks, and 1.6T scale-out networking readiness
— Leans on Finland's natural cooling and green energy advantages for efficiency
— Design separates facility infrastructure from compute hardware to ease future chip upgrades without disrupting operations
Not financial advice.
$TRUG's Polymath partners with High Ridge Trust on tokenization
— Polymath pairing its digital securities tech with High Ridge Trust's regulated custody and institutional infrastructure
— Deal covers custody, client-directed trading, and potential future yield opportunities for tokenized assets
— Comes as Polymath is being acquired by TruGolf, announced August 18, aimed at bringing Polymath's tokenization infrastructure onto US public markets
— Companies plan to identify joint technical and operational initiatives going forward
— Framed as building the bridge between traditional finance and institutional-grade tokenized capital markets
Not financial advice.
$PMTS prices secondary offering
— Parallel49 Equity-affiliated stockholders pricing 2,337,323 shares at $21.50 each
— Underwriters have a 30-day option for up to 350,598 additional shares
— Company itself isn't selling shares or receiving any proceeds, this is purely a selling stockholder offering
— Total gross proceeds to sellers expected around $50.3 million
— Expected to close on or about September 14, B. Riley and D.A. Davidson leading as bookrunners
Not financial advice.
$DBGI updates on go-private process and U.S. Program
— Received a proposal from an existing shareholder to take the company private at $77.58 per share cash
— Board retained Roth Capital Partners and opened a 60-day go-shop period running through October 5
— $165 million two-year U.S. Program contract now has a binding piece guaranteeing $3.3 million in cash flow from September through December
— Program covers apparel, footwear, and toiletries for over 771,000 US residents re-entering the workforce
— Company projecting $25-35 million in cash flow over the next 24 months, citing that against the buyout offer
Not financial advice.
$MIMI subsidiary teams up with Vengine on manufacturing
— Rice Robotics Hong Kong signs a non-exclusive framework agreement with Vengine to scale production
— Vengine will help identify manufacturers for mass production and recommend distribution partners across Asia
— Agreement is non-binding, no minimum purchase or revenue commitments, no statement of work signed yet
— Vengine's network includes a strategic tie to VTech Communications, a subsidiary of Hong Kong-listed VTech Holdings
— Framed as strengthening supply chain resilience as Rice Robotics scales its service robot business
Not financial advice.
$NXXT announces 1-for-10 reverse split
— Effective September 14, 2026 at 12:00am ET, ticker stays NXXT with new CUSIP
— Shares outstanding drop from about 168.4 million to roughly 16.8 million
— Applies to outstanding options, warrants, and convertible securities too
— No fractional shares issued, fractional entitlements rounded up to the next whole share
— Company deploys AI-driven Smart Controller tech across microgrids and utility-scale energy systems
Not financial advice.
$TNMG's Business Insider Taiwan hits 1.2M monthly page views
— Traffic more than doubled since June 2026, less than a year after launch
— Over 30% of readers now coming from overseas markets
— Launching two new original video/podcast programs in Q4 2026 to open new sponsorship revenue
Not financial advice.
$AUC completes GoldCoin Labs acquisition
— Became 100% shareholder of GoldCoin Labs, a gold-backed digital asset issuance infrastructure company
— Issued 2,815,005 ordinary shares as consideration, valued at approximately $20 million
— Company now has 22,128,378 ordinary shares issued and outstanding
— GoldCoin building infrastructure for Metra Gold (GOLDM), a token meant to represent one gram of physical gold on a 1:1 basis
— Independent fairness opinion from Pinetree Advisory backed the deal, board approved it unanimously citing exposure to the tokenized real-world asset sector
Not financial advice.
$ACHR joins ACES push for eVTOL charging in Texas
— Archer, BETA Technologies, and Macquarie Capital-led ACES expanding interoperable electric aviation charging across the state
— Working with TxDOT on charging site locations, supporting the White House's eVTOL Integration Pilot Program
— Test flights planned across the Texas Triangle and rural communities
— ACES targeting up to 250 US air-taxi sites, chargers built on an open standard for multiple operators
— Comes alongside Archer's No Roads city-to-city Midnight flight-test program spanning Texas, Florida, and New York
Not financial advice
$AVAV lands first international LOCUST laser weapon order
— Order worth over $50 million, buyer's identity not disclosed
— Covers initial LOCUST systems plus support services
— Comes right after the $464.8 million US Army E-HEL contract
— LOCUST targets Group 1-3 drones and other aerial threats, reportedly under $10 per shot
— Also investing over $30 million to expand Albuquerque manufacturing, potentially adding 450+ jobs
Not financial advice.
$HTOO's Al Shola Gas adds new LPG bobtail
— Expected to generate about $1.6M in annual recurring revenue at target run-rate
— Fleet now at 53 vehicles, fourth bobtail on order
— Also secured a Dubai Petroleum Products Permit strengthening its market position
Not financial advice.
$SKYX merges with smart home player Deako
— Signed merger agreement with Silicon Valley backed AI smart home company Deako, combining wall and ceiling plug-and-play tech
— Deako shipped over 32 million units in the past 5 years, with over $26 million in revenue in 2025
— Deako supplies over 50 US builders including D.R. Horton, Toll Brothers, and Shea Homes, opening a fast track into that channel
— SKYX issuing 25 million shares (18.46% of the company) under a 2-year lockup, plus $4M cash and an $8.5M note to Deako's lender
— Post-merger, current SKYX holders own 84.4%, Deako shareholders and lender own 15.6%
Not financial advice.
$MDCX publishes final Phase 2 SkinJect data
— Abridged Clinical Study Report for the completed Phase 2 posted on https://t.co/tsi3VwjkWN
— 200 microgram patch identified as the lead pivotal dose, all 90 enrolled patients completed the study with no discontinuations
— Findings feed directly into the FDA-authorized SKNJCT-005 program targeting Gorlin syndrome patients with multiple BCC lesions
— Company-commissioned market assessment models roughly $25,800 per treatment pricing, about $1.1 billion total addressable market, and up to $383 million peak US revenue potential
— Broader nodular BCC opportunity still open for a future strategic partner
Not financial advice.
$M Macy's Q2 2026 — comps up 2.7%, raises full-year guidance across the board
Numbers —
— Net sales: $4.9B, +1.1% YoY
— Comparable sales +2.7% — 5th straight quarter of growth
— Bloomingdale's comps +11.3%, best Q2 sales volume in brand history
— Bluemercury comps +6.2%
— GAAP diluted EPS: $0.62, +100% YoY; Adjusted diluted EPS: $0.63, +14% ex-tariff refund
— Adjusted EBITDA: $457M (9.0% of revenue) vs $373M last year
— Gross margin: 41.5%, +180bps YoY (mostly tariff refunds; ex-refund +10bps)
Balance sheet — $1.3B cash, $2.4B total debt, no material maturities until 2030. Repurchased $50M shares in Q2 ($100M YTD), ~$1.0B left on buyback authorization. Quarterly dividend of $0.1915/share declared
Guidance raised — FY2026 net sales now $21.675B-$21.825B (up from $21.5B-$21.75B), adjusted diluted EPS now $2.15-$2.35 (up from $2.00-$2.20)
Call today at 8:00am ET
Not financial advice.
$VNCE Q2 FY2026 net sales up 11.7% to $81.8M — raises full-year guidance
Numbers —
— Net sales: $81.8M vs $73.2M YoY, DTC +13.7%, wholesale +10.4%
— Adjusted EPS: $1.02 vs $0.38 last year
— Adjusted EBITDA: $18.0M vs $6.7M last year
— Gross margin: 60.9%, boosted by a $10.4M IEEPA tariff refund (ex-refund: 48.2%, in line with expectations)
OVO acquisition — closed Aug 27, ~$50M sales in CY2025, targeting $100M+ sales by FY2030
Guidance — FY2026 net sales +8-10% YoY (Vince business only, excludes OVO)
Not financial advice.